# Zoster Eye Disease Study

> **NCT03134196** · PHASE4 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 527 (actual)

## Conditions studied

- Herpes Zoster Ophthalmicus

## Interventions

- **DRUG:** Masked Placebo
- **DRUG:** Masked Oral Valacyclovir

## Key facts

- **NCT ID:** NCT03134196
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-23
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-07-22
- **Target enrollment:** 527 (ACTUAL)
- **Last updated:** 2025-03-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03134196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03134196, "Zoster Eye Disease Study". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03134196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*